
GC25593
LY3143921 hydrate
Also known as (3R)-3-(5-fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)-2H-isoindol-1-one;hydrate
LY3143921 hydrate is an orally administered ATP-competitive CDC7 inhibitor
ChemicalCAS1627696-53-0MW327.31FormulaC16H14FN5O2
- CAS number
- 1627696-53-0
- Molecular weight
- 327.31
- Formula
- C16H14FN5O2
- Solubility
- DMSO: 65 mg/mL (198·59 mM);Water: Insoluble;Ethanol: 32 mg/mL (97·77 mM)
- InChIKey
- WSICFXBHDWUFRU-PKLMIRHRSA-N
- Catalogue number
- GC25593
- Brand
- GLPBIO
Computed properties PubChem CID 156588327 · TPSA 84.6 Ų · H-bond donors 3 · H-bond acceptors 6
- TPSA
- 84.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 2
- Heavy atoms
- 24
SMILES C[C@@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F.O
Computed descriptors from PubChem (CID 156588327), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il